Literature DB >> 19095002

Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model.

Sarah R Meno1, Rebecca Nelson, Korry J Hintze, William T Self.   

Abstract

Monomethylarsonous acid (MMA(III)), a trivalent metabolite of arsenic, is highly cytotoxic and recent cell culture studies suggest that it might act as a carcinogen. The general consensus of studies indicates that the cytotoxicity of MMA(III) is a result of increased levels of reactive oxygen species (ROS). A longstanding relationship between arsenic and selenium metabolism has led to the use of selenium as a supplement in arsenic exposed populations, however the impact of organic arsenicals (methylated metabolites) on selenium metabolism is still poorly understood. In this study we determined the impact of exposure to MMA(III) on the regulation of expression of TrxR1 and its activity using a primary lung fibroblast line, WI-38. The promoter region of the gene encoding the selenoprotein thioredoxin reductase 1 (TrxR1) contains an antioxidant responsive element (ARE) that has been shown to be activated in the presence of electrophilic compounds. Results from radiolabeled selenoproteins indicate that exposure to low concentrations of MMA(III) resulted in increased synthesis of TrxR1 in WI-38 cells, and lower incorporation of selenium into other selenoproteins. MMA(III) treatment led to increased mRNA encoding TrxR1 in WI-38 cells, while lower levels of mRNA coding for cellular glutathione peroxidase (cGpx) were detected in exposed cells. Luciferase activity of TrxR1 promoter fusions increased with addition of MMA(III), as did expression of a rat quinone reductase (QR) promoter fusion construct. However, MMA(III) induction of the TRX1 promoter fusion was abrogated when the ARE was mutated, suggesting that this regulation is mediated via the ARE. These results indicate that MMA(III) alters the expression of selenoproteins based on a selective induction of TrxR1, and this response to exposure to organic arsenicals that requires the ARE element.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095002      PMCID: PMC2758422          DOI: 10.1016/j.taap.2008.11.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  48 in total

1.  Nuclear assembly of UGA decoding complexes on selenoprotein mRNAs: a mechanism for eluding nonsense-mediated decay?

Authors:  Lucia A de Jesus; Peter R Hoffmann; Tanya Michaud; Erin P Forry; Andrea Small-Howard; Robert J Stillwell; Nadya Morozova; John W Harney; Marla J Berry
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  Supramolecular complexes mediate selenocysteine incorporation in vivo.

Authors:  Andrea Small-Howard; Nadya Morozova; Zoia Stoytcheva; Erin P Forry; John B Mansell; John W Harney; Bradley A Carlson; Xue-Ming Xu; Dolph L Hatfield; Marla J Berry
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype.

Authors:  Jiaxin Li; Stephen B Waters; Zuzana Drobna; Vicenta Devesa; Miroslav Styblo; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2005-04-15       Impact factor: 4.219

4.  Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes.

Authors:  S Lin; L M Del Razo; M Styblo; C Wang; W R Cullen; D J Thomas
Journal:  Chem Res Toxicol       Date:  2001-03       Impact factor: 3.739

Review 5.  Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival.

Authors:  Jackob Moskovitz
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 6.  Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.

Authors:  Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim
Journal:  Free Radic Biol Med       Date:  2005-03-24       Impact factor: 7.376

7.  Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.

Authors:  Kylee E Eblin; Tiffany G Bredfeldt; Sarah Buffington; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2006-11-08       Impact factor: 4.849

8.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

9.  Elucidating the pathway for arsenic methylation.

Authors:  David J Thomas; Stephen B Waters; Miroslav Styblo
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

10.  Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts.

Authors:  Junko Aono; Toru Yanagawa; Ken Itoh; Baojie Li; Hiroshi Yoshida; Yoshito Kumagai; Masayuki Yamamoto; Tetsuro Ishii
Journal:  Biochem Biophys Res Commun       Date:  2003-05-30       Impact factor: 3.575

View more
  6 in total

1.  Hexavalent chromium-induced alteration of proteomic landscape in human skin fibroblast cells.

Authors:  Lei Guo; Yongsheng Xiao; Yinsheng Wang
Journal:  J Proteome Res       Date:  2013-06-11       Impact factor: 4.466

Review 2.  TrxR1 as a potent regulator of the Nrf2-Keap1 response system.

Authors:  Marcus Cebula; Edward E Schmidt; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

3.  Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials.

Authors:  Janet M Dowding; Soumen Das; Amit Kumar; Talib Dosani; Rameech McCormack; Ankur Gupta; Thi X T Sayle; Dean C Sayle; Laurence von Kalm; Sudipta Seal; William T Self
Journal:  ACS Nano       Date:  2013-05-23       Impact factor: 15.881

4.  Monomethylarsonous acid inhibited endogenous cholesterol biosynthesis in human skin fibroblasts.

Authors:  Lei Guo; Yongsheng Xiao; Yinsheng Wang
Journal:  Toxicol Appl Pharmacol       Date:  2014-03-10       Impact factor: 4.219

5.  Exposure to silver nanoparticles inhibits selenoprotein synthesis and the activity of thioredoxin reductase.

Authors:  Milan Srivastava; Sanjay Singh; William T Self
Journal:  Environ Health Perspect       Date:  2011-09-30       Impact factor: 9.031

6.  Epigallocatechin-3-gallate enhances key enzymatic activities of hepatic thioredoxin and glutathione systems in selenium-optimal mice but activates hepatic Nrf2 responses in selenium-deficient mice.

Authors:  Ruixia Dong; Dongxu Wang; Xiaoxiao Wang; Ke Zhang; Pingping Chen; Chung S Yang; Jinsong Zhang
Journal:  Redox Biol       Date:  2016-10-24       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.